Kotak has come out with its first quarter (April-June�� 18) earnings estimates for the Pharmaceuticals sector. The brokerage house expects HCG to report net profit at Rs. 7 crore down 85.8% year-on-year (down 74.1% quarter-on-quarter).
Net Sales are expected to increase by 20.5 percent Y-o-Y (up 3.6 percent Q-o-Q) to Rs. 230.3 crore, according to Kotak.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 11.9 percent Y-o-Y (up 2.5 percent Q-o-Q) to Rs. 33 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More First Published on Jul 18, 2018 03:04 pm
No comments:
Post a Comment